News/Compliance & Enforcement/Novartis Pays Over $642 Million to Settle Allegations of Improper Payments to Patients and Physicians

False Claims Act·Compliance & Enforcement Brief

Novartis Pays Over $642 Million to Settle Allegations of Improper Payments to Patients and Physicians

PubK AdminJuly 10, 2020 · 1 min read

🔒 Members Only

Novartis Pharmaceuticals Corporation has agreed to pay over $642 million combined in two settlements resolving FCA claims.

🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.

$750/year

Become a Member

Not ready to join? Take the free Pub K Weekly digest.One email. Free. Top industry articles, the community calendar, and the latest job postings.